Clinical aspects of mCRPC management in patients treated with radium-223

Bone is the most common site of metastasis in metastatic castration-resistant prostate cancer (mCRPC), which is associated with pain and skeletal events. Radium-223 dichloride (Xofigo) is an alpha-emitting radioactive isotope that can specifically target bone lesions. Herein, we report the results o...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Rizzini, Elisa Lodi, Dionisi, Valeria, Ghedini, Pietro, Morganti, Alessio Giuseppe, Fanti, Stefano, Monari, Fabio
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7174360/
https://ncbi.nlm.nih.gov/pubmed/32317750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63302-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items